Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.01 |
mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |